wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38612808-1C2F7629-9A07-4B9E-96C9-226B00644A8C
Q38612808-1C2F7629-9A07-4B9E-96C9-226B00644A8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612808-1C2F7629-9A07-4B9E-96C9-226B00644A8C
Axitinib: a review in advanced renal cell carcinoma.
P2860
Q38612808-1C2F7629-9A07-4B9E-96C9-226B00644A8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612808-1C2F7629-9A07-4B9E-96C9-226B00644A8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
40c22a4272187c80a95fb8d756a5e8ebb8d793d3
P2860
Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial.